Free Trial

Nano-X Imaging (NNOX) Competitors

Nano-X Imaging logo
$5.89 +0.20 (+3.51%)
(As of 11/20/2024 ET)

NNOX vs. AORT, ESTA, PLSE, BLFS, BVS, CBLL, EYE, FNA, LQDA, and AVNS

Should you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Artivion (AORT), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Bioventus (BVS), CeriBell (CBLL), National Vision (EYE), Paragon 28 (FNA), Liquidia (LQDA), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry.

Nano-X Imaging vs.

Nano-X Imaging (NASDAQ:NNOX) and Artivion (NYSE:AORT) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, community ranking, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Artivion has higher revenue and earnings than Nano-X Imaging. Artivion is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$9.90M34.38-$60.78M-$0.99-5.95
Artivion$384.90M2.96-$30.69M-$0.02-1,358.00

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 86.4% of Artivion shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 8.1% of Artivion shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Nano-X Imaging had 1 more articles in the media than Artivion. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for Artivion. Artivion's average media sentiment score of 1.76 beat Nano-X Imaging's score of 0.35 indicating that Artivion is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nano-X Imaging
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Artivion
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Nano-X Imaging received 5 more outperform votes than Artivion when rated by MarketBeat users. However, 78.57% of users gave Artivion an outperform vote while only 69.23% of users gave Nano-X Imaging an outperform vote.

CompanyUnderperformOutperform
Nano-X ImagingOutperform Votes
27
69.23%
Underperform Votes
12
30.77%
ArtivionOutperform Votes
22
78.57%
Underperform Votes
6
21.43%

Nano-X Imaging presently has a consensus target price of $14.00, suggesting a potential upside of 137.69%. Artivion has a consensus target price of $31.00, suggesting a potential upside of 14.14%. Given Nano-X Imaging's higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than Artivion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Artivion
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Artivion has a net margin of -0.22% compared to Nano-X Imaging's net margin of -567.41%. Artivion's return on equity of 5.15% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-567.41% -30.34% -26.99%
Artivion -0.22%5.15%1.91%

Nano-X Imaging has a beta of 2.01, indicating that its share price is 101% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500.

Summary

Artivion beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NNOX vs. The Competition

MetricNano-X ImagingX IndustryBusiness SectorNASDAQ Exchange
Market Cap$328.76M$31.06B$6.90B$8.81B
Dividend YieldN/A1.85%2.90%4.06%
P/E Ratio-5.9511.3645.9017.77
Price / Sales34.381.58171.6575.18
Price / CashN/A12.2124.0532.53
Price / Book1.663.535.044.68
Net Income-$60.78M$532.37M$121.42M$226.08M
7 Day Performance-2.32%-1.39%0.13%-1.04%
1 Month Performance-2.00%-14.31%8.32%1.04%
1 Year Performance-4.38%17.94%30.38%26.28%

Nano-X Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NNOX
Nano-X Imaging
1.7317 of 5 stars
$5.89
+3.5%
$14.00
+137.7%
-10.5%$328.76M$9.90M-5.95190
AORT
Artivion
1.9659 of 5 stars
$27.16
+0.9%
$31.00
+14.1%
+92.4%$1.14B$384.90M-1,358.001,500Positive News
ESTA
Establishment Labs
2.1311 of 5 stars
$41.81
+11.4%
$60.60
+44.9%
+90.0%$1.05B$165.15M0.00960High Trading Volume
PLSE
Pulse Biosciences
1.5329 of 5 stars
$16.14
-5.3%
N/A+157.8%$1.05B$700,000.000.00140Positive News
BLFS
BioLife Solutions
0.8729 of 5 stars
$25.01
+11.5%
$27.50
+10.0%
+86.5%$1.04B$146.96M-23.59409Analyst Forecast
Insider Trade
Analyst Revision
High Trading Volume
BVS
Bioventus
2.7241 of 5 stars
$11.41
-1.6%
$13.00
+13.9%
+195.6%$925.98M$555.06M-18.701,200Positive News
CBLL
CeriBell
N/A$25.06
-2.0%
$31.20
+24.5%
N/A$897.65MN/A0.00N/AQuiet Period Expiration
Analyst Revision
EYE
National Vision
3.0614 of 5 stars
$11.34
+0.5%
$14.00
+23.5%
-42.1%$888.30M$2.13B0.0013,998Positive News
FNA
Paragon 28
2.1549 of 5 stars
$10.35
-1.4%
$15.60
+50.7%
-0.3%$879.06M$216.39M0.00343,000Analyst Revision
LQDA
Liquidia
3.7407 of 5 stars
$10.12
-0.4%
$24.00
+137.2%
+55.7%$859.91M$17.49M0.0050Analyst Revision
AVNS
Avanos Medical
3.9807 of 5 stars
$17.87
+0.4%
N/A-16.6%$818.03M$673.30M52.563,771Positive News

Related Companies and Tools


This page (NASDAQ:NNOX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners